Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients. (Q34995574)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059921%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059921%20AND%20SRC:MED&resulttype=core&format=json

chronic renal insufficiency

22 February 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059921%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Denis Fouque

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059921%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Amanda F Barros

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059921%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

1 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059921%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059921%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059921%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059921%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

1317-1323

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059921%20AND%20SRC:MED&resulttype=core&format=json

The role of the gut microbiota in energy metabolism and metabolic disease

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

A dynamic partnership: Celebrating our gut flora

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

The human gut microbiome: ecology and recent evolutionary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

The influence of diet on the gut microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Gut microbial activity, implications for health and disease: the potential role of metabolite analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

The control and consequences of bacterial fermentation in the human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Influence of dietary protein supplements on the formation of bacterial metabolites in the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

NF-κB plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression, and inhibition of proliferation in proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Metabolism of dietary sulphate: absorption and excretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Nutritional aspects of dissimilatory sulfate reduction in the human large intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Luminal sulfide and large intestine mucosa: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Hydrogen sulfide as a vasodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Functional roles of KATP channels in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Intermittent hypoxia in rats increases myogenic tone through loss of hydrogen sulfide activation of large-conductance Ca(2+)-activated potassium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Low hydrogen sulphide and chronic kidney disease: a dangerous liaison.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Biological significance of dietary polyamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Mammalian polyamine metabolism and function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Polyamines in the anemia of end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Relevance of protein fermentation to gut health

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Resistant starch attenuates colonic DNA damage induced by higher dietary protein in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

p-Cresol and cardiovascular risk in mild-to-moderate kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

p-Cresyl sulfate promotes insulin resistance associated with CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Indoxyl sulfate is a nephro-vascular toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Indoxyl sulfate induces nephrovascular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Nutrition and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Eleven reasons to control the protein intake of patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Dietary protein restriction benefits patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Diet and cancer: assessing the risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Chronic kidney disease alters intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Protein carbamylation predicts mortality in ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Carbamylated low-density lipoprotein: nontraditional risk factor for cardiovascular events in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Gut microbiota and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

Probiotic amelioration of azotemia in 5/6th nephrectomized Sprague-Dawley rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

The in vivo use of the stable isotope-labelled biomarkers lactose-[15N]ureide and [2H4]tyrosine to assess the effects of pro- and prebiotics on the intestinal flora of healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.103

21 January 2018

Identifiers

DOI

10.2217/FMB.13.103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059921%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059921%20AND%20SRC:MED&resulttype=core&format=json